Topic

B.S Sathya Durga is Director at Acute Market Reports.

Articles

Guest contributor B.S. Sathya Durga discusses the importance of modernizing India's pharmaceutical manufacturing industry.

Frédéric Kahn is Generic APIs Commercial Head at Seqens.

Guest contributor Frederic Kahn discusses the state of the Indian pharmaceutical manufacturing industry.

Chris Spivey is the editorial director of 

Researchers from the Telomere-to-Telomere Consortium have discovered new properties about junk DNA that could have wide-reaching implications.

The process of reshaping inevitably leads to fresh insights.

Change of roster does not change the goal line. We are all patients first.

Rita C. Peters is the former editorial director of 

The mission continues. Let science be the guide.

Vaccines define the path to putting pandemic restrictions and pain in the rear-view mirror.

Bio/pharmaceutical manufacturers have made a good first step toward global vaccination through pledging doses at no- to low-profit rates. 

Mike Hennessy, Sr., is the founder and chairman of MJH Life Sciences.

Innovation drives the development of emerging drug modalities. 

As face masks start to come off, bio/pharma’s COVID-19 battle goes on.